Founder, Psychedelic Brief. Tracking Europe’s psychedelic medicine industry from Berlin.
Jul 7, 2026
•
4 min read
European psychedelic depression development just split into two camps. The dividing line is whether patients have to quit their antidepressants first.
Jun 30, 2026
5 min read
LSD just posted the biggest depression number in psychedelic Phase 3 history. It did it under the one design choice that sank EPIsoDE.
Jun 23, 2026
Lead Story: Europe's most advanced psychedelic Phase 3 just got its hardest question
Jun 16, 2026
3 min read
The psilocybin trials, the H1 review left out. Preview text: Two controlled European readouts complicate the real-world optimism. Here they are.
Jun 12, 2026
7 min read
In six months Europe stopped being a bystander. Mostly.
Jun 9, 2026
Week of 2 to 8 June 2026
Jun 3, 2026
2 min read
